Condition
Bietti's Crystalline Dystrophy
Total Trials
4
Recruiting
0
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Early P 1 (3)
P 1 (1)
Trial Status
Active Not Recruiting2
Unknown2
Clinical Trials (4)
Showing 4 of 4 trials
NCT05832684Phase 1Active Not RecruitingPrimary
Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
NCT06302608Early Phase 1Active Not RecruitingPrimary
Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy
NCT04722107Early Phase 1UnknownPrimary
Safety Study of rAAV2/8-hCYP4V2 in Patients With Bietti's Crystalline Dystrophy (BCD)
NCT05714904Early Phase 1UnknownPrimary
Safety and Tolerability of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
Showing all 4 trials